SELECT

(redirected from Selenium and Vitamin E Cancer Prevention Trial)
Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.
Selenium and Vitamin E Cancer Prevention Trial. A cancer prevention study evaluating the efficacy of antioxidants—e.g., selenium, vitamin E—in preventing prostate cancer
Conclusion Selenium or vitamin E did not prevent prostate cancer in a population of relatively healthy men

SELECT

A double-blind, placebo-controlled trial involving 32,400 men with apparently normal prostate glands and normal PSA levels, designed to determine the value of selenium and vitamin E in preventing prostate cancer. The trial was started in 2001 and the final results will not be available until 2013.
References in periodicals archive ?
In late October, the National Cancer Institute (NCI) decided to halt the Selenium and Vitamin E Cancer Prevention Trial (SELECT) because an initial, independent review of study data showed that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
The Selenium and Vitamin E Cancer Prevention Trial, or SELECT for short, is sponsored by the National Cancer Institute and is coordinated by the Southwest Oncology Group in San Antonio, Texas.
The Selenium and Vitamin E Cancer Prevention Trial, or SELECT, seeks to determine whether the two dietary supplements protect against prostate cancer, the second-most-common form of cancer in men after skin cancer.